These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
301 related items for PubMed ID: 12928390
1. TCR binding kinetics measured with MHC class I tetramers reveal a positive selecting peptide with relatively high affinity for TCR. Holmberg K, Mariathasan S, Ohteki T, Ohashi PS, Gascoigne NR. J Immunol; 2003 Sep 01; 171(5):2427-34. PubMed ID: 12928390 [Abstract] [Full Text] [Related]
2. Peptidic termini play a significant role in TCR recognition. Wang B, Sharma A, Maile R, Saad M, Collins EJ, Frelinger JA. J Immunol; 2002 Sep 15; 169(6):3137-45. PubMed ID: 12218131 [Abstract] [Full Text] [Related]
3. Potent T cell agonism mediated by a very rapid TCR/pMHC interaction. Boulter JM, Schmitz N, Sewell AK, Godkin AJ, Bachmann MF, Gallimore AM. Eur J Immunol; 2007 Mar 15; 37(3):798-806. PubMed ID: 17295390 [Abstract] [Full Text] [Related]
4. Ligand-specific selection of MHC class II-restricted thymocytes in fetal thymic organ culture. Kersh GJ, Engle DL, Williams CB, Allen PM. J Immunol; 2000 Jun 01; 164(11):5675-82. PubMed ID: 10820243 [Abstract] [Full Text] [Related]
5. The kinetics of two-dimensional TCR and pMHC interactions determine T-cell responsiveness. Huang J, Zarnitsyna VI, Liu B, Edwards LJ, Jiang N, Evavold BD, Zhu C. Nature; 2010 Apr 08; 464(7290):932-6. PubMed ID: 20357766 [Abstract] [Full Text] [Related]
6. Critical role for CD8 in binding of MHC tetramers to TCR: CD8 antibodies block specific binding of human tumor-specific MHC-peptide tetramers to TCR. Denkberg G, Cohen CJ, Reiter Y. J Immunol; 2001 Jul 01; 167(1):270-6. PubMed ID: 11418659 [Abstract] [Full Text] [Related]
7. Modulation of T cell function by TCR/pMHC binding kinetics. Carreño LJ, González PA, Kalergis AM. Immunobiology; 2006 Jul 01; 211(1-2):47-64. PubMed ID: 16446170 [Abstract] [Full Text] [Related]
8. A physiological ligand of positive selection is recognized as a weak agonist. Berg RE, Irion S, Kattman S, Princiotta MF, Staerz UD. J Immunol; 2000 Oct 15; 165(8):4209-16. PubMed ID: 11035053 [Abstract] [Full Text] [Related]
9. Interplay between TCR affinity and necessity of coreceptor ligation: high-affinity peptide-MHC/TCR interaction overcomes lack of CD8 engagement. Kerry SE, Buslepp J, Cramer LA, Maile R, Hensley LL, Nielsen AI, Kavathas P, Vilen BJ, Collins EJ, Frelinger JA. J Immunol; 2003 Nov 01; 171(9):4493-503. PubMed ID: 14568922 [Abstract] [Full Text] [Related]
10. Decreased binding of peptides-MHC class I (pMHC) multimeric complexes to CD8 affects their binding avidity for the TCR but does not significantly impact on pMHC/TCR dissociation rate. Dutoit V, Guillaume P, Ayyoub M, Hesdorffer CS, Luescher IF, Valmori D. J Immunol; 2003 May 15; 170(10):5110-7. PubMed ID: 12734357 [Abstract] [Full Text] [Related]
11. Homology between an alloantigen and a self MHC allele calibrates the avidity of the alloreactive T cell repertoire independent of TCR affinity. Hornell TM, Myers N, Hansen TH, Connolly JM. J Immunol; 2003 May 01; 170(9):4506-14. PubMed ID: 12707327 [Abstract] [Full Text] [Related]
12. T cell receptor binding kinetics required for T cell activation depend on the density of cognate ligand on the antigen-presenting cell. González PA, Carreño LJ, Coombs D, Mora JE, Palmieri E, Goldstein B, Nathenson SG, Kalergis AM. Proc Natl Acad Sci U S A; 2005 Mar 29; 102(13):4824-9. PubMed ID: 15772168 [Abstract] [Full Text] [Related]
14. Dissecting TCR-MHC/peptide complex interactions with A2/peptide multimers incorporating tumor antigen peptide variants: crucial role of interaction kinetics on functional outcomes. Dutoit V, Guillaume P, Cerottini JC, Romero P, Valmori D. Eur J Immunol; 2002 Nov 29; 32(11):3285-93. PubMed ID: 12555674 [Abstract] [Full Text] [Related]
15. High affinity xenoreactive TCR:MHC interaction recruits CD8 in absence of binding to MHC. Buslepp J, Kerry SE, Loftus D, Frelinger JA, Appella E, Collins EJ. J Immunol; 2003 Jan 01; 170(1):373-83. PubMed ID: 12496422 [Abstract] [Full Text] [Related]
16. Limits to the differential avidity model of T cell selection in the thymus. Girao C, Hu Q, Sun J, Ashton-Rickardt PG. J Immunol; 1997 Nov 01; 159(9):4205-11. PubMed ID: 9379014 [Abstract] [Full Text] [Related]
17. Distinct T cell interactions with HLA class II tetramers characterize a spectrum of TCR affinities in the human antigen-specific T cell response. Reichstetter S, Ettinger RA, Liu AW, Gebe JA, Nepom GT, Kwok WW. J Immunol; 2000 Dec 15; 165(12):6994-8. PubMed ID: 11120826 [Abstract] [Full Text] [Related]
18. A low affinity TCR ligand restores positive selection of CD8+ T cells in vivo. Stefanski HE, Mayerova D, Jameson SC, Hogquist KA. J Immunol; 2001 Jun 01; 166(11):6602-7. PubMed ID: 11359813 [Abstract] [Full Text] [Related]
19. Peripheral "CD8 tuning" dynamically modulates the size and responsiveness of an antigen-specific T cell pool in vivo. Maile R, Siler CA, Kerry SE, Midkiff KE, Collins EJ, Frelinger JA. J Immunol; 2005 Jan 15; 174(2):619-27. PubMed ID: 15634879 [Abstract] [Full Text] [Related]
20. Antibodies directed against the MHC-I molecule H-2Dd complexed with an antigenic peptide: similarities to a T cell receptor with the same specificity. Polakova K, Plaksin D, Chung DH, Belyakov IM, Berzofsky JA, Margulies DH. J Immunol; 2000 Nov 15; 165(10):5703-12. PubMed ID: 11067928 [Abstract] [Full Text] [Related] Page: [Next] [New Search]